Verthermia Heatt to Treat
Verthermia is dedicated to providing innovative hyperthermia cancer treatment through proprietary HEATT® technology. Their mission is to offer hope and healing to patients by targeting cancer cells with precision and care, using safe, non-invasive, and natural methods to extend and enhance life for those with advanced, unresponsive cancers. The company emphasizes a person-centered approach, focusing on dignity, compassion, and hope in cancer treatment.
Industries
Nr. of Employees
small (1-50)
Verthermia Heatt to Treat
Products
Extracorporeal whole-body hyperthermia system (blood heating and filtration circuit)
A clinical extracorporeal circuit combining an external blood heater, recirculating dialysate, adsorptive filtration and physiologic monitoring to heat and return blood for whole-body thermal therapy.
Extracorporeal whole-body hyperthermia system (blood heating and filtration circuit)
A clinical extracorporeal circuit combining an external blood heater, recirculating dialysate, adsorptive filtration and physiologic monitoring to heat and return blood for whole-body thermal therapy.
Services
Whole-body extracorporeal hyperthermia treatment
On-site hospital delivery of systemic hyperthermia by heating and recirculating a patient’s blood through an external perfusion circuit with integrated filtration and physiologic monitoring.
Clinical trial conduct and outcome monitoring for hyperthermia therapies
Design and execution of early‑phase clinical studies for extracorporeal hyperthermia, including enrollment of advanced cancer patients, protocol-driven treatments, biomarker and imaging monitoring, and survival/outcome analysis.
Peri-treatment patient support and quality-of-life monitoring
On-site coordination of patient support services, education and functional-status tracking during and after inpatient extracorporeal procedures to monitor daily-living outcomes and recovery.
Whole-body extracorporeal hyperthermia treatment
On-site hospital delivery of systemic hyperthermia by heating and recirculating a patient’s blood through an external perfusion circuit with integrated filtration and physiologic monitoring.
Clinical trial conduct and outcome monitoring for hyperthermia therapies
Design and execution of early‑phase clinical studies for extracorporeal hyperthermia, including enrollment of advanced cancer patients, protocol-driven treatments, biomarker and imaging monitoring, and survival/outcome analysis.
Peri-treatment patient support and quality-of-life monitoring
On-site coordination of patient support services, education and functional-status tracking during and after inpatient extracorporeal procedures to monitor daily-living outcomes and recovery.
Expertise Areas
- Extracorporeal perfusion system engineering
- Whole-body extracorporeal hyperthermia therapy
- Early‑phase oncology clinical trial management
- Peri-procedural anesthesia and inpatient critical care
Key Technologies
- Extracorporeal circulation and perfusion circuits
- External blood heating systems
- Dialysis-based blood filtration
- Adsorptive filtration (charcoal) modules